@article{a09f7a1f96554ab9a984e6d65f1131ef,
title = "Hemostatic and antithrombotic stewardship programs: A toolkit for program implementation",
abstract = "Hemostatic and antithrombotic agents are high-risk medications associated with high cost. The importance of anticoagulation stewardship has been recently highlighted by national organizations, but hemostatic stewardship programs remain underutilized. Several established hemostatic and/or antithrombotic stewardship programs have demonstrated a significant impact on the quality and cost of care provided to patients receiving these therapies. This review provides a comprehensive toolkit for development and implementation of combined hemostatic and antithrombotic stewardship programs.",
keywords = "anticoagulants, blood coagulation, hemostatics, patient safety",
author = "Dane, {Kathryn E.} and Naik, {Rakhi P.} and Streiff, {Michael B.} and Jennifer Yui and Satish Shanbhag and Nesbit, {Todd W.} and John Lindsley",
note = "Funding Information: Dr. Naik has received research funding from Riegel Pharmaceuticals and has served as a consultant for Elsevier. Dr. Streiff has received research funding from Janssen, Novo Nordisk, Roche, and Sanofi and has served as a consultant for Bayer, Janssen, Pfizer, and Portola and received honoraria for CME presentations from Bayer and Portola and has given expert witness testimony in various medical malpractice cases. Dr. Shanbhag reports institutional research support from Daiichi‐Sankyo and has served as a consultant for Takeda, GSK, Kura, Celgene, Beigene, and Daiichi‐Sankyo all outside the scope of the submitted work. Drs. Dane, Nesbit, and Lindsley have no relevant financial conflicts of interest to disclose. Funding Information: The authors would like to acknowledge Peggy Kraus, Pharm.D., and Vi Gilmore, Pharm.D., for their many contributions to institutional antithrombotic stewardship policies and resources. Publisher Copyright: {\textcopyright} 2022 Pharmacotherapy Publications, Inc.",
year = "2022",
month = jun,
doi = "10.1002/jac5.1614",
language = "English (US)",
volume = "5",
pages = "622--631",
journal = "JACCP Journal of the American College of Clinical Pharmacy",
issn = "2574-9870",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "6",
}